CPL’s Post

While the collective memory of the COVID 19 pandemic may be waning, at FasterCures, we have been capturing lessons learned from the pandemic experience since 2020 that point toward opportunities to improve the biomedical research ecosystem for other health crises. We see tremendous opportunity to expand research collaborations, accelerate product development, embed real world data and evidence in regulatory review, speed clinical trial innovation, make clinical trials more accessible and importantly, ensure diverse racial and ethnic populations are represented in trials. Following up on the recommendations outlined in our January 2021 “Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?” and the subsequent “Implementation Roadmap,” FasterCures released our newest report, “Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard.” How well are we doing on the lessons learned? From our engagement on the topics and interviews of 20 senior leaders in the field, we arrived at an overall grade of B-. While we uncovered a surprising number of positive developments, there remain significant impediments to protecting the progress that we saw during COVID-19.   Explore the scorecard for information about the overall grade of B- as well as grades and details across five broad areas including: research collaboration, acceleration of product development, clinical trial design and execution, collection and use of real-world data and evidence, and addressing racial and ethnic disparities in health care and research.   https://lnkd.in/egXZjTw7

Since the beginning of the COVID-19 pandemic, FasterCures has been capturing and reporting lessons learned, key takeaways, and opportunities for the medical biomedical research ecosystem. We developed a scorecard to assess our country’s current performance on our recommendations. Read our newest report to learn how we score in implementing lessons learned from COVID-19: https://lnkd.in/e6qnZR9j

Reflecting as we get closer to the end of 2023 - how do you think biomedical innovation is faring in a post-pandemic world? Check out FasterCures new scorecard for a start!

FasterCures has developed a post-pandemic scorecard to assess how well we have applied lessons learned from #COVID-19 in our biomedical research ecosystem. I am pleased to have contributed my perspective to this report. Read it to learn how the country scores in implementing #lessonslearned from the #pandemic: https://lnkd.in/grZ4chZb Michelle Longmire Kristin Schneeman Esther Krofah  

UPMC EVP’s Diane Holder and Tim Billiar, MD, discussed how #technology and #data can enhance patient and staff experiences in health care and how to implement a data-driven decision-making culture at the UPMC Enterprises Life Sciences Summit. Key takeaways from panel: https://bit.ly/3MXbMtg

learn more about the amazing work Nic Encina and his team have been up to.

With the goal of understanding the experiences of the extramural biomedical research community, The National Institutes of Health’s #UNITE Initiative convened 14 external listening sessions. The Summary Report describes the outreach efforts of the sessions, summarizes participants’ observations and proposed solutions, and presents information to support ongoing UNITE and #NIH efforts to identify and address structural racism and promote a diverse, equitable, and inclusive biomedical and behavioral research enterprise. Learn more about each session and the findings: https://lnkd.in/eBpwJriV

Ronnie Tepp, Principal at Pyxis Partners and Dr. Elizabeth Cohn, RN, PhD, FAAN, Vice President for Health Equity Research for Northwell Health at Feinstein Institutes for Medical Research, recently co-authored an opinion piece in the American Journal of Bioethics that speaks to the upstream and downstream factors necessary to consider in large scale research efforts designed to advance our understanding of genomics, its relationship to the social determinants of health, and precision medicine. Grateful for this collaboration and partnership and #PyxisProud to advocate for inclusion in health research as we continue to make impactful strides towards health equity! Read the article here: bit.ly/3xPDGmH #PyxisEngages

Ready for day 2 of the NIH conference, 'Advancing ME/CFS Research: Identifying Targets for Intervention and Learning from Long COVID.' Check out the full agenda here ➡️ https://bit.ly/3Rlm7k1 Pictured: Linda Tannenbaum, Open Medicine Foundation (OMF)’s Founder/CEO, greeting guests at OMF's informational booth! Attending in person? Stop by to say hello and learn more about our work to end #MECFS and #LongCOVID.